1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6440A0006836167B665258079001DF315
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-developing-high-value-competitive-intelligence-function-ci-benchmarks-structure-resources-competencies-customer-relationships?opendocument
18
19opendocument
20107.23.176.162
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Competitive and Business Intelligence Structure and Alignment

Competitive Intelligence Excellence: Structure, Resources, Competencies and Customer Relationships

ID: 5440


Features:

9 Info Graphics

20 Data Graphics

150+ Metrics

2 Narratives


Pages/Slides: 39


Published: 2016


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from Competitive Intelligence Excellence: Structure, Resources, Competencies and Customer Relationships”

STUDY OVERVIEW

An effective competitive intelligence function provides valuable insights that can help bio-pharmaceutical organizations to make better decisions, anticipate threats, and avoid corporate risks.

However, the competitive intelligence function is often undervalued in corporations, and competitive intelligence leaders often find themselves struggling for attention and resources.

Best Practices, LLC undertook benchmarking research to identify best practices and innovative methods for improving the strategic role and impact of the competitive intelligence function within the bio-pharmaceutical industry. In particular, this study provides benchmarks around the structure and leadership of the competitive intelligence function, appropriate budget and staffing levels, requisite employee competencies, and best practices for delivering customer value.


KEY TOPICS

  • CI Evolution & Trends
  • CI Structure & Leadership
  • CI Budget & FTE Levels
  • “How Much" Is Competitive Intelligence Used in the Organization
  • Top 5 CI Employee Skills
  • CI Customers & Customer Relationships
  • Best Practices & Lessons Learned

KEY METRICS
  • Structure and Reporting of Competitive Intelligence (CI) Groups
  • Budget Allocated to Key Competitive Intelligence Activities
  • Top Activities Used by the Competitive Intelligence Function
  • Use of Competitive Intelligence Output
  • Effective Metrics for Evaluating the Performance of CI Personnel
  • Top 5 Most Effective Formats for Delivering CI Insights to Internal Customers and Stakeholders
  • Effective Methods for Evaluating Internal Clients Satisfaction
  • Approaches Used by CI Groups to Promote their Corporate Value and Encourage Greater Usage from Internal Customers

SAMPLE KEY FINDINGS
  • Structure of CI Function: At 42% of the benchmarked companies, CI function has a hybrid structure, wherein some activities are centralized, others are done independently by individual departments or functional lines of business. A quarter of the companies have centralized structure while around 20% have a de-centralized CI function.

METHODOLOGY

Best Practices, LLC engaged 24 Competitive Intelligence leaders from 20 leading healthcare companies in this benchmarking study. Participants represented small, mid-size and large bio-pharmaceutical and medical device companies. Almost 60% of the participants work in U.S. locations.

Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Consulting; Research; Medical Device; Manufacturing; Science; Technology


Companies Profiled:
Abbott; Abbvie; Allergan; Array BioPharma; AstraZeneca; Boehringer Ingelheim; CSL Behring; Cubist Pharmaceuticals; Dr Reddy's Laboratories; Ethos Health Communications; GlaxoSmithKline ; IMS Health; Ipsen; Lonza Inc.; Medtronic; Pfizer; Phillips; Teleflex; Teva Pharmaceutical Industries Ltd; Waters


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.